Lonza Group Ltd. Introduces Clonetics® Rat Cardiac Myocytes

Basel, 09.10.2007 – Lonza announces the availability of Clonetics® Neonatal Rat Cardiac Myocytes for use in cardiovascular and toxicological research. These cryopreserved cells offer you functional, beating cardiac myocytes upon thaw, at your convenience. Cardiac myocytes provide research laboratories with ready to use primary cells for studies in areas such as cell contraction and physiology, ion channel flux, cardiac lipid metabolism and lipotoxicity, cardiac injury and apoptosis, inflammation, hypertension, and cytotoxicity.

MORE ON THIS TOPIC